Open AccessREVIEWING THE THERAPEUTIC ACTIVITY OF VITAMIN D WITH ANTIBIOTIC
Author(s) -
S Keerthana,
Kaushani Sen,
Richa Sadhwani,
Sakshi Karra
Publication year - 2021
Publication title -
international journal of medical and biomedical studies
Language(s) - English
Resource type - Journals
eISSN - 2589-8698
pISSN - 2589-868X
DOI - 10.32553/ijmbs.v5i9.2220
Subject(s) - medicine , azithromycin , vitamin d and neurology , cefuroxime , immunology , antibiotics , pharmacology , intensive care medicine , biology , microbiology and biotechnology
This article is an examination of the Rar The scientific development and subsequent “Vitamin D and antibodies” continues to influence the researchers all over the globe today. This article examines the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries and demonstrates further aspects of Therapeutic activity of vitamin D with antibiotic. Additionally, this article explores options for vitamin D with cefuroxime. Cefuroxime has been shown to severely impede fracture healing in rats, thus it should be avoided during fracture healing. Vitamin D with Amoxicillin. As it enhancers absorption of many intestinal permeation enhancers, it is very approachable for the pharma sector to invest and develop certain drugs without the fear of toxicity or insufficiency. Vitamin D with azithromycin. vitamin D selectively inhibits inflammatory cytokines, reducing the infiltration of leukocytes, neutrophils, monocytes / macrophages, and mast cells at the site of inflammation. Historical large-scale use and excellent safety record of azithromycin in respiratory infections are reliable. Hydroxychloroquine is a proposed new therapeutic agent in COVID 19 (viral pneumonia).
Key words: lyme diseases, intestinal permeation, COVID, inflammatory cytokines, warfarin therapy